Employee Navigator simplifies benefits & HR for brokers and HR departments around the country. We've built an all-in-one product that consolidates everything from benefits administration to compliance, onboarding and more into one place.\n\nEmployee Navigator works with the nation's leading insurance brokers to make it easier for companies of all sizes to run and grow their businesses. See how 25,000+ companies better manage over 3,000,000+ employees with Employee Navigator. www.employeenavigator.com

Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases. The Company's proprietary ARC-sparX platform separates the tumor-recognition and tumor-killing functions of conventional CAR-T cell therapies: (1) sparX (soluble protein antigen-receptor X-linkers) proteins recognize and bind specific antigens on diseased cells and flag those cells for destruction; and (2) ARC-T (Antigen Receptor Complex-T) cells bind the sparX proteins and kill the flagged cells. Arcellx has developed a collection of sparX proteins that bind different cell surface antigens. Administration of alternate sparX proteins can redirect ARC-T cells to different disease antigens to potentially address relapsed and refractory disease due to tumor heterogeneity or antigen escape. Additionally, ARC-T cell activity can be curbed as needed by controlling the dose and frequency of sparX administration.